Lixte Biotechnology Holdings, Inc..
LIXT.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Lixte Biotechnology Holdings, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing innovative therapies for cancer and other diseases. Their primary focus is on developing drugs that target protein phosphatase inhibitors, particularly those that can selectively in...Show More
Better Health for All
0
No data was available from the provided articles to assess Lixte Biotechnology Holdings, Inc. against the 'Better Health for All' ethical value. All article links resulted in 404 errors, indicating no information could be extracted for any KPI.
1
Fair Money & Economic Opportunity
0
No evidence available to assess Lixte Biotechnology Holdings, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, concrete data points for LIXT.US regarding fair pay, worker respect, or related metrics were found in the provided articles. The articles primarily focus on company financial and management updates. Regulatory actions and safety incidents detailed in Articles and pertain to Baxter Healthcare Corporation dba Baxter Bioscience, not LIXT.US, and are therefore not applicable to this assessment.
1
Fair Trade & Ethical Sourcing
0
No evidence available to assess Lixte Biotechnology Holdings, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, quantitative evidence was found in the provided articles to assess Lixte Biotechnology Holdings, Inc. against the defined KPIs for Honest & Fair Business. The Audit Committee Charter outlines responsibilities for financial oversight, audits, and complaint review, but it does not provide performance data, percentages, or specific policy details required by the rubric's quantitative thresholds for any KPI.
1
Kind to Animals
-70
The company conducts pre-clinical studies exclusively in animal models for drug development.
1
There is no formal animal testing policy disclosed in the provided information, only confirmation that animal testing is conducted.
2
Lixte Biotechnology Holdings, Inc. is involved in collaborative pre-clinical studies using animal models with the Netherlands Cancer Institute,
3
indicating no formal collaborations to develop industry-wide animal-free testing standards.
No War, No Weapons
0
No evidence available to assess Lixte Biotechnology Holdings, Inc. on No War, No Weapons.
Planet-Friendly Business
-10
Lixte Biotechnology Holdings, Inc. reported a waste diversion rate of 68.4% in 2024.
1
Respect for Cultures & Communities
0
No specific data for LIXT.US regarding formal partnerships, community reinvestment, cultural incidents, impact assessments, local employment, grievance mechanisms, complaint resolution, FPIC participation, community governance, cultural preservation investment, local procurement, indigenous suppliers, cultural site protection, social license, charitable giving to cultural organizations, community fund allocation, language inclusivity, cultural incident response, or cultural training completion was found in the provided articles.
1
The articles discuss general industry trends in diversity, equity, and inclusion but do not provide company-specific information relevant to the 'Respect for Cultures & Communities' KPIs for LIXT.US.
2
Safe & Smart Tech
0
No evidence available to assess Lixte Biotechnology Holdings, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess Lixte Biotechnology Holdings, Inc. on Zero Waste & Sustainable Products.